82VS
82VS is a venture studio that builds capital-efficient, asset-focused drug companies by partnering with founders, operators, and investors and providing access to an embedded discovery platform and services across antibody therapeutics, bispecifics, TCR-mimics, and genetic medicines. The studio supports company formation, fundraising and early-stage operations through strategy, legal support, and R&D funding to accelerate progression to Series A.
Industries
N/A
Products
Aakha Biologics (portfolio company)
A portfolio company focused on discovery and development of biologic therapies for oncology indications.
Aldebaran Therapeutics (portfolio company)
A portfolio company developing genetic-medicine approaches for ocular disease.
Broadwing Bio (portfolio company)
A portfolio company developing antibody therapies for major causes of adult vision loss.
Cantai (portfolio company)
A portfolio company developing bispecific antibodies for immune-mediated and autoimmune diseases.
Voro (portfolio company)
A portfolio company developing tumor-activated antibodies for cancer immunotherapy targeting myeloid cells.
Synkentro (portfolio company)
A portfolio company developing agonists targeting immunosuppressive receptors for autoimmune disease treatment.
Aakha Biologics (portfolio company)
A portfolio company focused on discovery and development of biologic therapies for oncology indications.
Aldebaran Therapeutics (portfolio company)
A portfolio company developing genetic-medicine approaches for ocular disease.
Broadwing Bio (portfolio company)
A portfolio company developing antibody therapies for major causes of adult vision loss.
Cantai (portfolio company)
A portfolio company developing bispecific antibodies for immune-mediated and autoimmune diseases.
Voro (portfolio company)
A portfolio company developing tumor-activated antibodies for cancer immunotherapy targeting myeloid cells.
Synkentro (portfolio company)
A portfolio company developing agonists targeting immunosuppressive receptors for autoimmune disease treatment.
Services
Venture studio services
Company formation, co-building, and operational support for early-stage biotech ventures delivered through partnership and embedded platform access.
Capital formation and fundraising support
Assistance with capital strategy, investor introductions, and fundraising readiness to advance companies toward Series A.
Operational and portfolio management
Fund and portfolio operations, capital formation, and hands-on operational support for launched companies.
Venture studio services
Company formation, co-building, and operational support for early-stage biotech ventures delivered through partnership and embedded platform access.
Capital formation and fundraising support
Assistance with capital strategy, investor introductions, and fundraising readiness to advance companies toward Series A.
Operational and portfolio management
Fund and portfolio operations, capital formation, and hands-on operational support for launched companies.
Expertise Areas
- Venture studio and early-stage company formation
- Antibody therapeutics discovery
- Bispecific antibody discovery
- T cell receptor mimic discovery
Key Technologies
- Antibody discovery and engineering
- Bispecific antibody engineering
- T cell receptor mimic (TCRm) discovery
- Genetic medicines (gene therapy / genetic modalities)